Reviva Pharmaceuticals Hldg Inc
(RVPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,178 | 11,974 | 23,368 | 4,972 | 11,152 |
| TOTAL | $7,233 | $13,497 | $23,700 | $5,387 | $11,842 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 820 | 0 | 0 | 0 | 0 |
| TOTAL | $820 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $8,053 | $13,497 | $23,700 | $5,387 | $11,842 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,693 | 5,721 | 3,849 | 5,278 | 2,648 |
| Accrued Expenses | 8,598 | 8,062 | 12,925 | 7,532 | 6,338 |
| TOTAL | $13,944 | $14,492 | $17,175 | $13,033 | $9,208 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 150 | 351 | 807 | 873 | 1,013 |
| TOTAL | $150 | $351 | $807 | $873 | $1,013 |
| Total Liabilities | $14,094 | $14,843 | $17,982 | $13,907 | $10,221 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,817 | 27,919 | 27,919 | 22,650 | 22,650 |
| Common Shares | 3 | 3 | 3 | 2 | 2 |
| Retained earnings | -149,648 | -141,788 | -134,354 | -120,708 | -110,217 |
| TOTAL | $-6,042 | $-1,346 | $5,719 | $-8,519 | $1,621 |
| Total Liabilities And Equity | $8,053 | $13,497 | $23,700 | $5,387 | $11,842 |